A critical discovery in cancer research is arising with the use of VHH fragments to reactivate mutated p53. This crucial malignant protector protein is frequently disabled in several forms of tumors, leading https://bookmarkick.com/story21996069/mini-antibodies-restore-the-p53-protein-new-promising-hope-for-malignant-treatment